2019/08/31 by Francesco Cosentino, Peter J Grant, Massimo Francesco Piepoli +140 · 6 citations
Economics, Econometrics and Finance · Medicine · #Clinical practice guidelines implementation #Health Systems, Economic Evaluations, Quality of Life #Lipoproteins and Cardiovascular Health
paper · pdf · doi:10.1093/eurheartj/ehz486
openalex publication_date 2019/08/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
The Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EASD are not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.